Rising Prevalence Of Contagious Diseases Drives Growth In Adult Vaccine Market: A Significant Driver Propelling The Adult Vaccines Market In 2025

The Adult Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Adult Vaccines Market Size and Projected Growth Rate?
Recent years have seen robust expansion in the size of the adult vaccines market. Projected growth indicates that the market will expand from $22.82 billion in 2024 to $24.49 billion in 2025, fueled by a compound annual growth rate (CAGR) of 7.3%. The historical growth is attributable to factors such as the aging population, government-led vaccination initiatives, escalating awareness about preventive healthcare, advancements in vaccine development and innovation, and widespread public health campaigns.

The market for adult vaccines is anticipated to significantly expand in the upcoming years, with predictions placing it at $35.22 billion by 2029, and a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this projected growth, within the predicted period, include the manifestation of new infectious risks, an intensified focus on vaccination records, escalating threats from antimicrobial resistance, worldwide efforts directed towards pandemic readiness, a shift towards personalized vaccines, and a heightened emphasis on maternal immunization. Key trends set to shape this period are the integration of digital health, technological advancements in the production of vaccines, partnerships between governments and pharmaceutical companies, advancements in vaccine delivery technologies and broadening immunization programs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

What Are the Major Segments in the Adult Vaccines Market?
The adult vaccines market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals

Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Are The Driving Adult Vaccines Market Evolution?
The escalating occurrence of infectious diseases is propelling the growth of the adult vaccine market. Infectious diseases are illnesses that can be transmitted from one individual to another. Vaccines are instrumental in helping an individual develop resistance against these diseases, making them an effective tool against infections. To put this into context, in March 2023, the Centers for Disease Control and Prevention, a nationally recognized public health organization in the US, indicated that a total of 8,300 tuberculosis cases were reported in 2022 in comparison with 7,874 in 2021. The incidence rate for TB in 2022 saw a slight increase to 2.5 cases per 100,000 individuals as compared to 2.4 in 2021. Hence, the escalation in the occurrence of infectious diseases is acting as a catalyst for growth in the adult vaccine market.

Which Firms Dominate The Adult Vaccines Market Segments?
Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

What Trends Are Expected to Dominate the Adult Vaccines Market in the Next 5 Years?
In the field of adult vaccines, product innovation is becoming an increasingly noticed trend. Leading companies in the market are launching novel products to maintain their market status. For instance, GSK, a biopharma company from the UK, and IQVIA, a global firm from India specializing in advanced analytics, technology solutions, and clinical research services brought to market Vaccine Track in August 2022. This platform offers a data trend service designed to boost adult vaccination in communities across the country. The resource will supply regular and pertinent data focused on supporting and strengthening public health initiatives.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Is The Largest Region In The Adult Vaccines Market?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Adult Vaccines Market?
2. What is the CAGR expected in the Adult Vaccines Market?
3. What Are the Key Innovations Transforming the Adult Vaccines Industry?
4. Which Region Is Leading the Adult Vaccines Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.